11 Jan New Eye Cancer Treatment Approved
A rare childhood eye cancer, retinoblastoma, is now the latest disease to be treated by intraocular injection....
A rare childhood eye cancer, retinoblastoma, is now the latest disease to be treated by intraocular injection....
Ozurdex has been approved for the treatment of macular swelling caused by retinal vascular problems. In my own practice, Ozurdex is becoming more useful. It signifies the beginning of a new era!...
There are risks to every medical procedure. The risks of intravitreal injections are low, but include blindness from infection and possibly retinal detachment. How to safeguard against infection from intraocular injections....
Ophthotec announces potential for new macular degeneration treatment. Their anti-PDGF treatment may be better than anti-VEGF alone....
Avastin, Lucentis and Macugen are effective treatments for wet macular degeneration. I prefer to using Avastin and begin treatment with a series of 3 injections. Other retina specialists practice similarly....
Lucentis is the second anti-VEGF drug FDA approved for the treatment of wet macular degeneration. It is an effective treatment for wet macular degeneration. The formulation differs from Macugen and Avastin as do the visual results....
Macugen (pegaptanib) was the first anti-VEGF intraocular injection for the treatment of wet macular degeneration. How it works and a review of this novel retinal treatment for macular degeneration....
Intraocular injections are commonly used to treat macular degeneration and diabetic retinopathy. anti-VEGF medications are useful and successful treatment for these eye diseases. More "injections" are expected as more medicines are developed....